|
Published in Volume
101, Issue 6 (March 15,1998)
J. Clin. Invest.
101(6):
1415-1423 (1998).
doi:10.1172/JCI375.
Copyright ©
1998, The American Society for
Clinical Investigation.
Research Article
Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease.
A Pelet,
O Geneste,
P Edery,
A Pasini,
S Chappuis,
T Atti,
A Munnich,
G Lenoir,
S Lyonnet and
M Billaud
Unité de Recherches sur les Handicaps Génétiques de l'Enfant INSERM U-393, Paris Cedex 15, France.
Published March 15,
1998
Hirschsprung's disease (HSCR) is a common congenital malformation characterized by the absence of intramural ganglion cells of the hindgut. Recently, mutations of the RET tyrosine kinase receptor have been identified in 50 and 15-20% of familial and sporadic HSCR, respectively. These mutations include deletion, insertion, frameshift, nonsense, and missense mutations dispersed throughout the RET coding sequence. To investigate their effects on RET function, seven HSCR missense mutations were introduced into either a 1114-amino acid wild-type RET isoform (RET51) or a constitutively activated form of RET51 (RET-MEN 2A). Here, we report that one mutation affecting the extracytoplasmic cadherin domain (R231H) and two mutations located in the tyrosine kinase domain (K907E, E921K) impaired the biological activity of RET-MEN 2A when tested in Rat1 fibroblasts and pheochromocytoma PC12 cells. However, the mechanisms resulting in RET inactivation differed since the receptor bearing R231H extracellular mutation resulted in an absent RET protein at the cell surface while the E921K mutation located within the catalytic domain abolished its enzymatic activity. In contrast, three mutations mapping into the intracytoplasmic domain neither modified the transforming capacity of RET-MEN 2A nor stimulated the catalytic activity of RET in our ligand-independent system (S767R, P1039L, M1064T). Finally, the C609W HSCR mutation exerts a dual effect on RET since it leads to a decrease of the receptor at the cell surface and converted RET51 into a constitutively activated kinase due to the formation of disulfide-linked homodimers. Taken together, our data show that allelic heterogeneity at the RET locus in HSCR is associated with various molecular mechanisms responsible for RET dysfunction.
|
|
Articles that cite
this article:
Genetic basis of Hirschsprung’s disease
Paul K. H. Tam, Mercè Garcia-barceló
Pediatr Surg Int 25(7):543. [CrossRef] RET(MEN 2B) is active in the endoplasmic reticulum before reaching the cell surface
P Runeberg-roos, H Virtanen, M Saarma
Oncogenes 26(57):7909. [CrossRef] Implication of expression of GDNF/Ret signalling components in differentiation of bone marrow haemopoietic cells
Seiko Nakayama, Ken-ichi Iida, Toyonori Tsuzuki, Toshihide Iwashita, Hideki Murakami, Naoya Asai, Yosuke Iwata, Masatoshi Ichihara, Shinji Ito, Kumi Kawai
Br J Haematol 105(1):50. [CrossRef]
William Belknap
CURR OPIN GASTROENTEROL 18(1):74. [CrossRef]
Amanda Capes-davis, Bruce Robinson
CURR OPIN ENDOCRINOL DIABETES 6(1):61. [CrossRef]
The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease
Richard Škába, Šárka Dvořáková, Eliška Václavíková, Petr Vlček, Miroslava Frantlová, Běla Bendlová
Pediatr Surg Int 22(12):991. [CrossRef] Implication of expression of GDNF/Ret signalling components in differentiation of bone marrow haemopoietic cells
Seiko Nakayama, Ken-ichi Iida, Toyonori Tsuzuki, Toshihide Iwashita, Hideki Murakami, Naoya Asai, Yosuke Iwata, Masatoshi Ichihara, Shinji Ito, Kumi Kawai
Br J Haematol 105(1):50. [CrossRef] RET and NTRK1 proto-oncogenes in human diseases
Marco A. Pierotti, Luisella Alberti, Cristiana Carniti, Claudia Miranda, Emanuela Roccato
J Cell Physiol 195(2):168. [CrossRef] RET receptor signaling: Dysfunction in thyroid cancer and Hirschsprung's disease
Naoya Asai, Mayumi Jijiwa, Atsushi Enomoto, Kumi Kawai, Kengo Maeda, Masatoshi Ichiahara, Yoshiki Murakumo, Masahide Takahashi
Pathol Int 56(4):164. [CrossRef] Co-segregation of MEN2 and Hirschsprung's disease: The same mutation ofRET with both gain and loss-of-function?
Masahide Takahashi, Toshihide Iwashita, Massimo Santoro, Stanislas Lyonnet, Gilbert M. Lenoir, Marc Billaud
Hum Mutat 13(4):331. [CrossRef] RET andGDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems
Robert M.W. Hofstra, Ying Wu, Rein P. Stulp, Peter Elfferich, Jan Osinga, Saskia M. Maas, Liesbeth Siderius, Alice S. Brooks, Jenneke J. Vd ende, Vera M.R. Heydendael
Hum Mutat 15(5):418. [CrossRef] Cell signalling and gene expression mediated by RET tyrosine kinase
K Kurokawa, K. Kawai, M. Hashimoto, Y. Ito, M. Takahashi
J Intern Med 253(6):627. [CrossRef] Molecular diagnosis of multiple endocrine neoplasia Type 2
Maria Joao Bugalho, Rita Domingues, Luis Sobrinho
Expert Rev Mol Diagn 3(6):769. [CrossRef] Receptors that mediate cellular dependence
D E Bredesen, P Mehlen, Walfik S Ei-deiry
Cell Death Differ 12(8):1031. [CrossRef] Molekularbiologie, Grundlagenforschung und Diagnose des Morbus Hirschsprung
G. Martucciello, O. Luinetti, P. Romano, U. Magrini
Pathologe 28(2):119. [CrossRef] A complex additive model of inheritance for Hirschsprung disease is supported by both RET mutations and predisposing RET haplotypes
Macarena Ruiz-ferrer, Raquel M. Fern??ndez, Guillermo Anti??olo, Manuel L??pez-alonso, Charis Eng, Salud Borrego
8(11):704. [CrossRef]
|
